Abstract
The efficient binding of receptors Lk (Lk = L5‐L8) to [Eu(hfac)3] (H‐hfac = 1,1,1,5,5,5‐hexafluoropentane‐2,4‐dione) allows (i) to gather the basic unit‐containing tridentate ligands Lk and the acidic unit‐bearing bidentate hfac− co‐ligands into a stable single molecular [Lk Eu(hfac)3] adduct working as a catalyst for Michael C─C bond formations, (ii) to enhance the acidity of the N‐H units connected to the benzimidazole side arms of the bound ligands L5 and L7, and (iii) to reorganize their geometries into cis‐cis conformation for activating Michael substrates 1 and 2 through H‐bonding interactions on the second‐sphere coordination to provide the target product 3 (up to 92% yield). A maximum enantiomeric excess of 21% could be achieved due to the long distance between the chiral sources and the catalytic sites in the europium complexes. Stepwise distortions from planarity of the terdentate Lk ligands in the yttrium complexes [Lk Y(hfac)3] (Lk = L2, L3, and L5‐L10) can be tuned by addition of specific substituent into the benzimidazole side arms, thus realizing some control over their dual fluorescence and phosphorescence emission properties. All [Lk Eu(hfac)3] (Lk = L2, L3, and L5‐L10) complexes display europium‐centered photoluminescence properties induced by the antenna effect and modulated by the specific design of the light‐harvesting aromatic ligand located in the first coordination sphere.
Keywords: bifunctional catalyst, europium complexes, metal‐template, michael reaction, photoluminescence quantum yield
The Michael donor and the Michael acceptor are activated via hydrogen bonding interactions within the second‐sphere coordination of europium complexes.

1. Introduction
Among the carbon‐carbon bond‐forming techniques, the Michael reaction discovered by Arthur Michael in 1887, exhibits a recognizable role in providing critical precursors for constructing bioactive molecules and natural products in organic synthesis.[ 1 , 2 , 3 , 4 ] This transition‐metal‐free transformation is based on conjugate addition, or 1,4‐addition, of a carbon nucleophile (Michael donor) to an activated olefin (Michael acceptor) in the presence of a Brønsted base to form a new carbon‐carbon bond with perfect atom economy (Scheme 1a).[ 1 , 2 ] Moreover, it requires mild conditions and tolerates a wide range of functional groups which are molecularly attached to the Michael substrates.[ 5 , 6 ] However, the Michael reaction still represents certain difficulties, including competing reactions (such as polymerization of Michael acceptors, self‐aldolization of Michael donors, and 1,2‐addition reaction), poor reaction yields without an acid co‐catalyst as well as the lack of enantiocontrol of newly formed quaternary carbon center in the Michael product.[ 7 , 8 , 9 , 10 , 11 , 12 ]
Scheme 1.

a) Michael reaction reported by Athur Michael in 1887, b) DABCO‐catalyzed reaction between 6 and 7, c) addition of 9 to 10 in the coexistence of acid and base catalysts, d) asymmetric addition of 13 to 2 with the help of the chiral bifunctional catalyst 14.
As illustrations: (i) the DABCO‐catalyzed addition of 6 to 7 gave the Michael adduct 8 in moderate 45% reaction yield due to the competing polymerization of nitroolefin 7 (Scheme 1b),[ 10 ] (ii) the Michael reaction of cyclohexanone 9 to alkylidene malonate 10 in the presence of the base catalyst 11 afforded the desired product 12 in only 38% yield, while the catalytic combination of 11 and 3,5‐dinitrosalicyclic acid maximized the reaction yield up to 99% (Scheme 1c).[ 12 ] A huge effort has been therefore focused on the design of chiral bifunctional organocatalysts such as proline derivatives, cinchona alkaloids, urea/thiourea‐containing tertiary amine, peptides for controlling chemical conversion as well as enantioselectivity in the asymmetric Michael addition.[ 13 , 14 , 15 , 16 , 17 ] These chiral dual‐site organocatalysts carry two different functional groups for simultaneously activating both Michael donor and Michael acceptor substrates to improve reaction rate and stereocontrol of the chemical process.[ 6 , 18 , 19 ] As an example, Takemoto and coworkers successfully positioned a tertiary amine and a thiourea unit on molecule 14 for catalyzing the Michael reaction between malonate 13 and nitroolefin 2 to generate compound 15 with excellent productivity and enantioselectivity (Scheme 1d).[ 17 ] In this case, the tertiary amine unit in 14 promotes the enolization of malonate 13, while the thiourea moiety in 14 activates nitroolefin 2 via hydrogen interactions; altogether accelerating the reaction rate as well as the chirality transfer from the catalyst to the formed compound 15.
The binding of a metal ion to organic ligands has been exploited for more than 40 years to gather and structurally reorganize the coordinated ligands into specific orientations required for their subsequent inter/intramolecular reactions.[ 20 , 21 , 22 ] In this context, Sauvage and coworkers used Cu(I) to appropriately link two aromatic bidentate ligands for directing the synthesis of interlocked molecules.[ 20 ] The groups of Gunnlaugsson and Leigh exploited the high coordination numbers (up to 12) in lanthanide complexes to increase the ligand density connected to Ln(III) center for promoting intercomponent reactions between the bound ligands.[ 23 , 24 ] Recently, our group reported the use of trivalent lanthanide ions to (i) benefit from the trans‐trans to cis‐cis conformation change of free to bound ligand for positioning the reactive end groups on the same side and accelerating the ring‐closing metathesis reaction of the bound ligand,[ 25 ] and (ii) suppress the confinement of Rh/Ru catalysts into the nitrogen cavity of tridentate ligands and facilitate Rh/Ru‐based intermolecular couplings.[ 26 , 27 ] Trivalent europium complexes coordinating organic ligand chromophores have emerged as superior candidates in multifaceted fields such as light‐emitting diodes, biomedical probes, temperature sensors due to their pure red luminescence and highly selective sensing.[ 28 , 29 , 30 , 31 ] Ligand‐centered singlet excited state in europium complexes generated upon light absorption populates the ligand‐based spin‐forbidden triplet state, which then intramolecularly transfers its energy to the central europium ion for producing metal‐induced red emissions.[ 32 ] This energy transfer process is therefore mainly governed by the antenna ligand structure. When the ligand‐based triplet state level is located close in energy to the receiving levels of trivalent europium ion, a competing back energy transfer from metal to bound ligand can occur, leading to a reduced sensitized photoluminescence quantum yield.[ 33 , 34 ] Adjusting this energy gap by ligand design to enhance luminescence properties of the europium complexes continues to attract the attention of organic chemists.[ 35 , 36 , 37 ] Tridentate 2,6‐bis‐(benzimidazol‐2‐yl)pyridine derivatives (Scheme 2) and bidentate β‐diketonates are well‐known chelating sensitizer agents to efficiently induce photoluminescence of Eu(III) due to their strong coordination behaviors, their tunable molecular architecture (substituted, flexible, preorganized, rigid, extended conjugated, planar) as well as their attractive properties, such as thermal stability and volatility.[ 38 , 39 , 40 ] In this contribution, we report the use of trivalent europium ion (i) to integrate the basic unit‐bearing tridentate ligand Lk (Scheme 2) and the acidic unit‐containing bidentate hfac− into a single molecule for developing new bifunctional catalysts and promoting the Michael reaction, (ii) to enhance the reactivity of functional group in the bound ligands and appropriately dispose the reactive groups into favorable directions required for their catalytic activity, and (iii) to reexamine the influence of aromatic ligand structures on the Eu‐centered photoluminescence quantum yields.
Scheme 2.

Synthesis of the target ligands a) L1‐L3, b) L4‐L8; and c) chemical structures of previously prepared ligands L9‐L12 discussed in this contribution,.
2. Results and Discussion
Synthesis and structural characterization of tridentate ligands L k (L k = L1‐L8) and their europium complexes [L k Eu(hfac)3].
The synthesis of the tridentate building blocks L1‐L8 (Scheme 2) is detailed in the Supporting Information. The synthetic strategy is based on (i) the Philips condensation reaction between a diamine and a dicarboxylic acid to build the 2,6‐bis‐(benzimidazol‐2‐yl)pyridine framework and (ii) substitution reactions at the benzimidazole side arms to control the number of remaining N‐H acid units. Two commercial compounds, (S)‐(+)1‐bromo‐2‐methylbutane and (S)‐(−)‐N‐benzyl‐α‐methylbenzylamine, were used as chiral sources to introduce the chirality into the target ligands. Slow evaporation of dichloromethane/hexane solutions gave single crystals of L1·CH2Cl2, L2·0.5CH2Cl2, L3, L4·CH3OH·2H2O, and L5 suitable for X‐ray analysis (Appendix 2). Their solid‐state structures display trans‐trans conformations which (i) optimize inter‐site dipole interactions[ 41 , 42 ] and (ii) avoid steric repulsions between the N‐H/N‐alkyl groups attached to the benzimidazole side arms and the aromatic protons of the pyridine center (Figure 1a). The lack of NOESY correlation between the aromatic protons of the pyridine ring and those of the N‐substituent in CD2Cl2 confirms the maintain of similar trans‐trans organization in solution (Appendix 1). The crystal structures of ligands L1 and L4 display nearly planar geometries reflected in the minor dihedral angle (average of 5.220) between the pyridine and the nonsubstituted benzimidazole side arms (Tables A2‐3 and A2‐14). Introduction of alkyl groups into the benzimidazole side arms in L2, L3, L5 leads to a distortion visualized by increased pyridine‐benzimidazole interplanar angles ranging from 13.92(5)° to 44.65(12)° (Tables A2‐7, A2‐11, and A2‐18). The quality of the crystal structure of the amphoteric ligand L5 is sufficient to unambiguously establish that the benzimidazole ring is protonated and the terminal trialkyl‐amine is deprotonated as illustrated in Figure 1a. This proton distribution is maintained in solution since both the associated NOESY spectrum (Figure A1‐28) and the HMBC spectrum (Figure A1‐30) point to the N(H) acid unit being localized within the benzimidazole side arm. The treatment of Lk (Lk = L2, L3, and L5‐L8) with [digEu(hfac)3] (dig = diglyme or bis(2‐methoxyethyl)) results in the formation of the target complexes [Lk Eu(hfac)3], as suggested by the downfield shift of the aromatic protons located close to the paramagnetic europium(III) center (Figure 6a,b), which can be isolated in 66–92% yields. Recrystallization by slow evaporation of dichloromethane/hexane solutions affords single crystals of [L2Eu(hfac)3]·0.25CH2Cl2·0.5C6H14, [L3Eu(hfac)3], [L5Eu(hfac)3]·H2O, [L6Eu(hfac)3], [L7Eu(hfac)3], and [L8Eu(hfac)3]·0.25CH2Cl2 suitable for X‐ray analysis (Figure 2 and Appendix 2). All crystal structures exhibit nine‐coordinate complexes, in which the Eu(III) center is encompassed by three nitrogen atoms of the bound aromatic ligand Lk (Lk = L2, L3, and L5‐L8) and by six oxygen atoms from three bidentate hfac− co‐ligands. The coordinated aromatic ligands adopt the cis‐cis arrangement required for chelate coordination, which is evidenced by their molecular structures observed in the solid state. In CD2Cl2 solution, related cis‐cis arrangements are ascertained by the detection of NOESY correlations between the proton of N‐alkyl groups connected to the lateral benzimidazole rings and the protons of the central pyridine unit. The crystal structure of [L5Eu(hfac)3]·H2O is worth being highlighted because one guest water molecule is doubly hydrogen bound to (i) the basic exocyclic nitrogen atom of the bound ligand L5 and (ii) the acidic (N)H of the benzimidazole side arm (Figure 1b). This host‐guest interaction suggests a potential substrate accommodation in this cavity and some acid‐base bifunctional catalytic ability of the bound aromatic ligand L5 toward the Michael reaction. The replacement of the hydrogen atoms connected to the nitrogen atoms of the benzimidazole side arms with alkyl substituents induces steric repulsions with the hydrogen atoms of the central pyridine ring, which results in twists of the benzimidazole‐pyridine units (average dihedral angle = 3(3)° for (HN)benzimidazole‐pyridine and 23(8)° for (alkyl‐N)benzimidazole‐pyridine) in [Lk Eu(hfac)3] (Lk = L2, L3, L5, L6, L8) complexes (Tables A2‐22, A2‐25, A2‐28, A2‐32, A2‐42). The latter intramolecular interaction is lacking in [L7Eu(hfac)3] complex, and a nearly planar structure is found for the bound ligand L7 (dihedral angle = 2.8(2)°, Table A2‐35). Finally, the chirality of each synthesized compound was confirmed by measuring its specific rotation in CH2Cl2 (Table A2‐43). The nonzero specific rotations indicate that all final compounds are optically active in solution (Table A2‐43).
Figure 1.

Crystal structures of a) one of the two independent molecules in the asymmetric unit of free L5 ligand, and b) one of the four molecules in the asymmetric unit of [L5Eu(hfac)3]·H2O. Color codes: C = gray, N = blue, O = red, F = light yellow, Eu = green, H = orange.
Figure 6.

Activations of the Michael substrates by the aliphatic tertiary amine group and a) the acid unit C‐H of hfac− in [L6Eu(hfac)3], and b) the acidic N‐H group of the benzimidazole side arm in [L5Eu(hfac)3] complex.
Figure 2.

Synthesis and molecular structure of [Lk Eu(hfac)3] (Lk = L2, L3, and L5‐L8) complexes. Color codes: C = gray, N = blue, O = red, F = yellow, Eu = green. Hydrogen atoms have been omitted for clarity.
2.1. Thermodynamic Behavior of L7 and L8 Hosts With [Eu(hfac)3] Guest in Dichloromethane Solution
The stability constants of [L7Eu(hfac)3] and [L8Eu(hfac)3] complexes were determined by 1H NMR titrations of the free ligands L7 and L8 with [digEu(hfac)3] in CD2Cl2 solution according to Eq. 1.
| (1) |
Using an excess of dig (0.14 M) to stabilize the activity coefficients of chemical substances at millimolar concentrations upon the 1H NMR titration,[ 43 ] the ligand exchange constant described in eq. 1 transforms into the conditional binding constant shown in Eq. 2.
| (2) |
Experimentally, at each point of the host‐guest titration, the recorded 1H NMR spectrum (Figure 3) affords reliable integrations for the same proton corresponding to the coordinated and to the free ligands, from which the associated occupancy factor (Eq. 3) and the free concentration of the trivalent lanthanide guest in solution can be calculated for building the experimental binding isotherms (black diamonds in Figure 4).
| (3) |
Figure 3.

1H NMR titration of L7 with [digEu(hfac)3] in CD2Cl2 + 0.14 M dig at 293 K.
Figure 4.

Experimental (black diamonds) and fitted binding isotherms using eq. 3 (dashed‐red trace) and eq. A3‐3 (dashed‐green trace) for the titrations of a) L7, and b) L8 with [digEu(hfac)3] in CD2Cl2 + 0.14 M dig at 293 K.
The conditional stability constants can be estimated for [L7Eu(hfac)3] and [L8Eu(hfac)3] complexes by nonlinear least‐squares fits of versus (red trace in Figure 4) with the help of eq. 3 (second line). They are collected in Table 1.
Table 1.
Thermodynamic conditional and exchange stability constants determined for the titration of L7 and L8 ligands with [digEu(hfac)3] in CD2Cl2 + 0.14 M dig at 293 K.
| [L7Eu(hfac)3] | [L8Eu(hfac)3] | ||
|---|---|---|---|
|
|
9700(400) | 2100(200) | |
|
|
1358(60) | 290(24) |
The removal of steric congestion between the hydrogen atoms of the central pyridine and the isopentyl groups bound to the benzimidazole side arms in going from [L8Eu(hfac)3] to [L7Eu(hfac)3] results in a significant increase (∼5x) of the association constant (Table 1). The synthesized europium complexes are used as catalysts for Michael reactions conducted at 0.025 M (see next section) in dry dichloromethane solution. Based on the stability constants collected in Table 1, one can estimate that 99.9% of the target heteroleptic europium complexes [Lk Eu(hfac)3] are present in solution at this concentration during the Michael reactions.
2.2. Catalytic Activity of Ligands Lk and Their Europium Complexes
The Michael reaction between conjugated β‐nitrostyrene 2 (1eq.) and diethyl malonate 1 (2 eq.) has been selected to evaluate the catalytic behavior of the free ligands Lk and their europium complexes (Table 2).
Table 2.
Results of Michael reactions between malonate 1 and nitrostyrene 2
| ||||
|---|---|---|---|---|
| Entry | Catalyst | Time /h | Yield /%[ a ] | ee /%[ b ] |
| 1 | DMAP | 24 | 9 | ND[ c ] |
| 2 | [digEu(hfac)3] | 168 | NR[ d ] | ‐ |
| 3 | Et3N | 24 | 23 | ND |
| 4 | L1 [ e ] | 168 | NR | ‐ |
| 5 | L2 | 168 | NR | ‐ |
| 6 | L3 | 168 | NR | ‐ |
| 7 | L4 | 168 | NR | ‐ |
| 8 | L5 | 168 | NR | ‐ |
| 9 | L6 | 168 | NR | ‐ |
| 10 | L7 | 336 | NR | ‐ |
| 11 | L8 | 336 | NR | ‐ |
| 12 | [L2Eu(hfac)3] | 168 | NR | ‐ |
| 13 | [L3Eu(hfac)3] | 168 | NR | ‐ |
| 14 | [L5Eu(hfac)3] | 24 | 55 (57)[ f ] | 7 |
| 15 | [L5Eu(hfac)3] | 72 | 92 (92) | 9 |
| 16 | [L6Eu(hfac)3] | 24 | 38 (42) | 0 |
| 17 | [L6Eu(hfac)3] | 72 | 72 (83) | 3 |
| 18 | L6+[digEu(hfac)3] | 72 | 47[ f ] | ND |
| 19 | L6+[Eu(tfc)3] | 72 | NR | ‐ |
| 20 | [L7Eu(hfac)3][ g ] | 336 | 25 (28) | 21 |
| 21 | [L8Eu(hfac)3][ g ] | 336 | 18[ h ] (12) | 20 |
| 22 | [L11Eu(hfac)3] | 168 | NR | ‐ |
Isolated yield.
Not determined (ND).
Reaction conducted in CH2Cl2/CH3OH (1/1).
The reaction was conducted with 5 equivalents of compound 1.
A small amount of impurity is present in the isolated product.
The reaction is first conducted at room temperature in dry dichloromethane solution (0.25 M) for 24 hours by using 4‐dimethylamino‐pyridine (DMAP) as Bronsted base catalyst (entry 1) at a fixed loading of 10 mol % to generate the desired product 3 in only 9% yield. This reaction is not completed within 24 hours, visualized by the signals of the unreacted starting Michael acceptor 2 in the 1H NMR spectrum of the reaction mixture shown in Figure A1‐130c. However, the DMAP‐bearing ligands L1‐L3 display no catalytic activity in the discussed reaction despite the reaction time being extended for 168 hours (entries 4–6). Their catalytic deficiencies could be accounted for by the reduced basicity of amine‐nitrogen atoms implied in the π‐delocalization between the central DMAP unit and the lateral benzimidazole rings. Replacement of the aromatic nitrogenous base DMAP with the stronger aliphatic base Et3N results in a slightly higher 23% yield (entry 3), together with the detection of an insoluble solid side‐product resulting from the polymerization of β‐nitrostyrene (Figure A1‐129). The polymeric by‐product exhibits an extremely poor solubility in organic solvent, implying difficulties in structural characterization of polymer product in solution by spectroscopies. To clarify the formation of the side product, two additional reactions were carried out: one between compounds 2 and 1, and another between compound 2 and Et3N. After 24 hours, a formed solid was only observed in the mixture of nitrostyrene 2 and Et3N (Figure A1‐129). The 1H NMR spectrum of this precipitate resembled that obtained from the Michael reaction catalyzed by Et3N (Figure A1‐134), indicating that the insoluble solid results from the polymerization of monomeric precursor 2.[ 11 , 44 ] Unexpectedly, all Et3N‐containing ligands L4‐L6 do not show any catalytic behavior for both the Michael reaction and for polymerization despite the presence of complementary acid N‐H groups borne by the benzimidazole side arms in L4 and L5 (entries 7–9). The failure of the Michael reaction could be explained by (i) the reduced reactivity of tertiary amine moiety caused by the negative inductive effect of oxygen atom attached to the pyridine ring, and (ii) the weak hydrogen‐binding ability of acid N‐H units belonging to the benzimidazole side arm.
Next, we evaluate the catalytic capability of the europium complexes. When [L6Eu(hfac)3] complex is employed as the catalyst, the Michael product 3 is formed in 38% yield after 24 hours (entry 16) and in 72% after 72 hours (entry 17). The formation of the desired compound is visualized by the appearance of new signals marked with an asterisk in the 1H NMR spectrum of reaction mixture (Figure 5). The [L6Eu(hfac)3] catalyst remains stable as confirmed by its characteristic signals in the 1H and 19F NMR spectra of the reaction mixtures (Figures 5e, A1‐132c, A1‐133e, and A1‐133f). The DOSY spectrum of reaction mixture recorded after 72 hours (Figure A1‐137) separates the NMR signals into three components according to their molecular translational diffusion coefficients: the Michael substrates, the Michael product, and the catalyst, further confirming the absence of catalyst decomposition during the 1,4‐addition process. Moreover, the catalyst [L6Eu(hfac)3] is recovered in 62% yield from the Michael reaction (entry 17) by size exclusion chromatography thanks to the significant difference in molecular weights between the catalyst and the Michael substrates/product. In the reaction mechanism, the aliphatic tertiary amine group of the aromatic ligand assists the enolization of the Michael donor 1, while the two oxygen atoms in NO2 group of the Michael acceptor 2 noncovalently interact with the acidic proton (C)‐H of the coordinated hfac‐ through hydrogen bonding connection Figure 6a).
Figure 5.

1H NMR spectra of a) ligand L6, b) complex [L6Eu(hfac)3], c) β‐nitrostyrene 2, d) diethyl malonate 1, e) reaction mixture from entry 16 (*: signals of formed compound), and f) desired product 3 in CD2Cl2.
The target Michael reaction attempted in the absence of exocyclic amine‐nitrogen atom in [L11Eu(hfac)3] complex (entry 22, Figure A1‐139) displays no conversion, proving the important role of basic moiety attached to the pyridine ring. The combination of L6 and [digEu(hfac)3] is also found to drive the discussed reaction to the Michael product 3 in 47% yield after 72 hours (entry 18). The 1H NMR spectrum of the latter reaction mixture (Figure A1‐132d) shows the characteristic signals of [L6Eu(hfac)3] and dig, revealing the reaction of L6 with [digEu(hfac)3] for generating [L6Eu(hfac)3] which subsequently catalyzes the Michael reaction. The combination of L6 and commercially available europium tris[3‐(trifluoromethylhydroxymethylene)‐(+)‐camphorate [Eu(tfc)3] displays no catalytic activity in the Michael reaction (entry 19, Figure A1‐132e), denoting the role of acidic proton (C)‐H of the coordinated hfac‐ in [Eu(hfac)3] containers. Interestingly, [L5Eu(hfac)3] shows an improved catalytic activity reflected in higher reaction yields after 24 hours (entry 14) and 72 hours (entry 15) as compared to those promoted by [L6Eu(hfac)3] complex (entries 16 and 17). The N‐H group connected to the benzimidazole side arm in the bound aromatic ligand available in [L5Eu(hfac)3] catalyst becomes more acidic upon complexation to the central metal. It can capture the electrophilic NO2 group of compound 2 and therefore enhance the Michael reaction performance (Figure 6b). In this case, Eu(III) plays a considerable role in (i) facilitating the assembly of two base and acid components into a single scaffold, (ii) enhancing the reactivity of the functional group N‐H for catching electrophilic reagents, and (iii) reorganizing the bound ligand L5 into the cis‐cis conformation required for the catalytic process. However, the level of chirality transfer from these europium‐based scaffolds to the Michael product 3 is disappointing due to the long distance between the chiral carbon center in [Lk Eu(hfac)3] complexes (Lk = L5 and L6) and the hydrogen‐binding sites.
Recrystallization by slow evaporation of dichloromethane/hexane solution of compound 3 from entry 17 affords its single crystal suitable for X‐ray analysis (Figure A2‐14). Compound 3 displays a reversible phase transition upon cooling during X‐ray diffraction analysis, causing crystal lattice rearrangement and consequently slightly damaged crystals at low temperature 120 K (Figures A2‐15 and A2‐17). Its crystal structure can be solved at all temperatures (180 K, 150 K and 120 K) and exhibits a racemic arrangement (Figure A2‐16). Positioning the chiral center closer to the basic amine nitrogen atom in the bound tridentate ligands L7 and L8 leads to slightly improved chirality transfer from [Lk Eu(hfac)3] complexes to the Michael product 3 with 21% ee. However, the reaction yields are dramatically reduced due to the steric hindrance induced by the bulky substituents close to the active nitrogen and should be improved for practical applications.
2.3. Photophysical Properties of Free Ligands and Their Lanthanide [LkLn(hfac)3] Complexes
The UV‐Vis absorption spectra of L1‐L8 recorded in CH2Cl2 solution at room temperature are dominated by the broad bands in the region of 32 260–32 790 cm−1 assigned to the spin‐allowed 1π1*←1π transition (Figure 7a). The gradual introduction of substituent at the nitrogen atom of the benzimidazole side arms leads to a somewhat blue‐shift of the lowest‐energy 1π1*←1π transition along the L1→L2→L3, L4→L5→L6, and L7→L8 series due to the less efficient electronic connection between the central pyridine and the lateral benzimidazole rings caused by the distortion in the ligand scaffold. A blue‐shift in the 1π1*←1π transition is also observed upon connecting an electron donating heteroatoms (O and N) to the 4‐position of the pyridine center along the series L11 (30 675 cm−1) → L8 (32 362 cm−1) ≈ L6 (32 154 cm−1) → L3 (34 014 cm−1). The room temperature emission spectra of ligands L1‐L10 are acquired under excitation at absorption maxima of each antenna ligand (Figures 7b and A4‐3), from which the observed ligand‐based singlet excited 1π1*→1π transitions are determined and collected in Table A4‐1. Despite differences in structural distortion in the ground state, identical emission spectra are observed along the L1→L2→L3, L4→L5→L6, and L7→L8 series (Figure A4‐3). Interestingly, in frozen dichloromethane solution at 77 K, all heteroatom‐(Br, N, O)‐substituent‐bearing L1‐L10 ligands display both 1π1*→1π fluorescence and 3π1*→1π phosphorescence emissions (Figure A4‐3), while the peripheral heteroatom‐free L11 and L12 models exhibit only fluorescence bands. This phenomenon could be explained by the presence of the heavy‐atom Br and the lone‐pair electrons in (N, O) atoms, which allow the spin‐forbidden singlet‐triplet interaction to proceed more efficiently by increasing spin‐orbit coupling in agreement with previous studies.[ 45 , 46 , 47 ] Moreover, at cryogenic temperature, nonradiative processes (intermolecular motion, vibrational relaxation, solvent quenching) are significantly reduced, allowing the detection of long‐lived phosphorescence emission. The intensity of phosphorescence emission at low temperature is enhanced along the L3→L2→L1, L6→L5→L4, and L8→L7 series while increasing planarity degree in the ligand frameworks. A planar ligand backbone can facilitate overlap of π‐orbitals upon singlet‐triplet interactions, improving intersystem crossing efficiency and triplet state population.[ 48 , 49 ] The close‐to‐planar ligands L1, L4, and L7 display exclusively phosphorescence signal at low temperature, while emission profiles of their di‐alkylated distorted L3, L6, and L8 analogues are dominated by fluorescence bands under similar condition. Control over the emission properties from phosphorescence to fluorescence in Lk (Lk = L1‐L8) emitters is realized by stepwise introduction of substituent onto the benzimidazole side arms for tuning the planarity of the polyaromatic ligands. Remarkably, the preorganized ligand L9 displays a phosphorescence band at much lower energy compared to its halogen‐bearing L10 model and its halogen‐free Lk (Lk = L1‐L8 and L11) analogues. The crystal structure of L9 shows a distortion of the vinylene unit from the pyridine plane due to the H···H repulsion between the methyl group bound to the pyridine ring and the vinylene unit of CH2‐CH = CH bridge.[ 25 ] The planarization of the distorted backbone L9 upon photoexcitation leads to the electronic communication between the benzimidazole‐pyridine system and the double bond of the CH = CH‐CH2 fragments, enhancing the triplet state stability and lowering its energy level.[ 50 , 51 , 52 ] The distorted (10π+2π+6π+2π+10π = 30π)‐containing L9 and the planar (30π)‐bearing L12 ligands thus exhibit a similar time‐gated phosphorescence profile recorded in glassy solution at 77 K with a pulsed xenon lamp source (Figure 7c). A red shift of the phosphorescence transition is observed along the L3→L11→(L9 ≈ L12) series (Figure 7c) according to the electronic localization/delocalization within ligand scaffold.
Figure 7. a).

Absorption spectra of ligands L1‐L12. b) Normalized 293K‐emission spectra of L3 (λexc = 310 nm), L8 (λexc = 326 nm), L9 (λexc = 435 nm), L10 (λexc = 429 nm), L11, and L12. c) Normalized 77K‐phosphorescence spectra of L3 (λexc = 310 nm), L9 (λexc = 435 nm), L11, and L12.[ 27 ] d) 293K‐Absorption (left) and normalized emission (right, λexc = 350 nm) spectra of [Lk Y(hfac)3] (Lk = L3, L8‐L10), and [Lk La(hfac)3] (Lk = L11, L12)[ 27 ] complexes. e) Normalized 77k‐phosphorescence spectra (λexc = 350 nm) of [Lk Y(hfac)3] (Lk = L3, L9), and [Lk La(hfac)3] (Lk = L11, L12)[ 27 ] complexes. f) Normalized 293K‐emission spectrum (λexc = 350 nm) of [L9Eu(hfac)3] complex.
In order to estimate the ligand‐centered singlet and triplet excited energy levels in the [Lk Eu(hfac)3] (Lk = L2, L3, and L5‐L10) complexes, the ligand‐based photophysical properties are investigated in the corresponding yttrium complexes [Lk Y(hfac)3] (Lk = L2, L3, and L5‐L10, synthesis is detailed in Appendix 1), which possess no accessible f‐electron level for being involved in intramolecular energy communication with the ligand‐based excited levels. The comparison with the electronic absorption profile of [digY(hfac)3] represented in Figures 7d and A4‐1 demonstrates that excitation at 350 nm (28 571 cm−1) into the aromatic ligands Lk (Lk = L2, L3, and L5‐L10) in [Lk Y(hfac)3], for performing emission measurements, prevents the contribution of hfac− to the light conversion process. The emission spectra of these yttrium complexes are shown in Figures 7d (right) and A4‐4, from which the bound ligand‐centered singlet excited transitions are established and gathered in Table A4‐2. Remarkably, heavy‐metal‐induced spin‐orbit coupling in the [L7Y(hfac)3] and [L8Y(hfac)3] complexes leads to dual fluorescence and phosphorescence emissions at room temperature; a rare behavior in these lanthanide adducts, which broadens potential practical applications in optoelectronic devices, smart anti‐counterfeiting, data encryption, and biomedicine due to their long lifetime and large shift between absorption and emission spectra.[ 53 ] The emission spectra of the [Lk Y(hfac)3] (Lk = L2, L3, and L5‐L10) complexes, now recorded at 77 K, display both fluorescence and phosphorescence signals, while the related closed‐shell lanthanum complexes [L11La(hfac)3][ 27 ] and [L12La(hfac)3][ 27 ] exhibit only fluorescence profile in agreement with observations found in the corresponding free ligand (Figure A4‐4). Time‐resolved phosphorescence spectra of [L3Y(hfac)3] and [L9Y(hfac)3] are recorded in glassy solution at 77 K with a pulsed xenon lamp source (Figure 7e), allowing the detection of ligand‐based triplet excited 3π1*→1π transitions and completing the Jablonski diagrams for light conversion process in lanthanide complexes (Figure 8). When Y3+ is replaced with Eu3+ in the [Lk Eu(hfac)3] complexes (Lk = L2, L3, and L5‐L10), photoexcitation at 350 nm into the aromatic ligand‐centered excited states produces systematically the five characteristic Eu‐centered f‐f transitions: 5D0→7F0, 5D0→7F1, 5D0→7F2, 5D0→7F3, and 5D0→7F4 (Figures 7f and A4‐5a). The intense narrow signal at 614 nm is responsible for the pure red emission color of the Eu(III) ion. The excitation spectra monitored at 614 nm of the europium complexes shown in Figure A4‐6 are like their ground‐state absorption spectra, confirming that the bound ligand absorbs light and transfers its energy to the metal center via the antenna mechanism. The overall Eu‐centered quantum yield of [Lk Eu(hfac)3] (Lk = L2, L3, and L5‐L10) complexes upon ligand excitation is determined using the relative method with 9,10‐diphenylanthracene as the fluorescence standard (Table 3). [Lk Eu(hfac)3] (Lk = L2, L3, L5‐L8, and L10) complexes show similar and remarkable total photoluminescence quantum yield 60%) due to their comparable triplet excited state energy levels, which dominate the sensitization process (Figure 7a). The connection of electron‐donating (O, N) and electron‐withdrawing (Br) groups to the tridentate ligand framework does not affect the sensitization efficiency of the antenna ligand for europium‐centered luminescence. However, [L9Eu(hfac)3] displays a dramatically decreased photoluminescence quantum yield of % upon photoexcitation. This behavior could be attributed to back energy transfer (BET) from the emissive Eu‐centered levels to the low‐energy triplet excited 3π1*→1π state due to their minor energy difference (Figure 7b), thereby reducing the ligand‐sensitized photoluminescence quantum yield. The room temperature emission spectrum of [L9Eu(hfac)3] (Figure 7f) displays residual 1π1*→1π and 3π1*→1π transitions compatible with BET process, which vanishes when the temperature is reduced to 77 K (Figure A4‐5b).
Figure 8.

Jablonski diagrams built for a) [L3Eu(hfac)3], and b) [L9Eu(hfac)3] complexes.
Table 3.
Photoluminescence quantum yield of the target europium complexes.
3. Conclusion
All (Brønsted base unit)‐bearing ligands L1‐L8 display no catalytic behavior for the Michael reaction between the Michael donor 1 and the Michael acceptor 2 due to the weak reactivity or the absence of an acidic group in their scaffolds. Trivalent europium ion is therefore exploited to not only (i) enhance the acidity of N‐H unit of the bound aromatic ligand in [Lk Eu(hfac)3] (Lk = L5 and L7), but also (ii) structurally constrain the bound ligands in the cis‐cis orientation required for bifunctional catalytic ability and (iii) introduce additional acidic bidentate β‐diketonate co‐ligands into the molecular assemblies for activating simultaneously the two Michael substrates 1 and 2 on the second‐sphere coordination of the central metal for producing compound 3 with a yield of up to 92% after 72 hours. However, these bifunctional catalysts display a limited enantioselectivity, attributed to the significant spatial separation between the chiral carbons and the hydrogen‐binding sites in the catalysts scaffold.
Emission parameters in the free ligands Lk (Lk = L2, L3, and L5‐L10) and in their yttrium complexes [Lk Y(hfac)3] can be tuned from fluorescence to phosphorescence by controlling the planarity of their backbones in the ground state. At room temperature, [L7Y(hfac)3] and [L8Y(hfac)3] display a rare dual fluorescence/phosphorescence emission promoted by the heavy‐metal effect. The direct attachment of electron‐donating (O, N) and electron‐withdrawing (Br) groups to the aromatic ligands scaffold displays no effect on the sensitization efficiency of the bound ligands for europium‐based luminescence. Planarization of the bound L9 ligand in the triplet excited state induces electronic delocalization within the sensitizer scaffold in the europium complex and consequently lowers its triplet excited state energy level, causing a poor photoluminescence quantum yield for [L9Eu(hfac)3] in comparison with its [Lk Eu(hfac)3] (Lk = L2, L3, L5‐L8, and L10) analogues.
This work highlights a rare case of dual functionality for lanthanide complexation, which induces catalytic properties on one part (Michael addition) and efficient light downshifting on the other side.
4. Experimental Section
General
All reagents were purchased from Alfa Aesar, FluroChem, Acros, Fischer Chemicals AG, and Sigma‐Aldrich, and used as received. Compounds S1 [ 54 ] and [digEu(hfac)3][ 55 ] were prepared according to literature. THF was distilled over sodium/benzophenone under nitrogen atmosphere. The CCDC deposition numbers for the crystal structures of the synthesized compounds can be found in ref. [56].
L1
A mixture of S1 (1.4 g, 6.7 mmol) and 1,2‐phenyldiamine (1.65 g, 15 mmol) in 85% H3PO4 (25 mL) was stirred at 220 °C under nitrogen atmosphere for 6 hours and then poured into 300 mL of cold water. The pH was adjusted to pH 9 with 25% NH4OH. The formed precipitate was filtered off and redissolved in hot DMSO (300 mL). H2O (300 mL) was added. The precipitate was filtered and dried overnight under reduced pressure to give L1 as a white solid (1.38 g, 59%).1H NMR (400 MHz, DMSO‐d6): 12.87 (s, 2H), 7.74 (d, J = 7.9 Hz, 2H), 7.69 (d, J = 1.1 Hz, 2H), 7.58 (s, 2H), 7.33 (t, J = 1.3 Hz, 2H), 7.26 (t, J = 1.2 Hz, 2H), 3.18 (s, 6H). 13C NMR (101 MHz, DMSO‐d6): 156.06, 151.89, 148.10, 144.36, 134.62, 123.85, 122.54, 119.81, 112.09, 103.98. ESI‐MS calculated for [C21H18N6 + H]+ ([L1 + H]+): m/z 355.2; found: 355.6.
L2
A mixture of L1 (1.50 g, 4.23 mmol) and 60% NaH (0.51 g, 12.75 mmol) in dry THF (50 mL) was stirred at r.t for 1 hour. (S)‐(+)1‐bromo‐2‐methylbutane (1.96 g, 12.98 mmol) and KI (catalytic amount) were added. The solution was heated at 50 °C for 24 hours and then quenched with water (50 mL). The mixture was extracted with CH2Cl2 (3×50 mL), dried over Na2SO4 and evaporated to dryness. The residue was purified by column chromatography (SiO2, CH2Cl2/MeOH 100/0 to 100/3) to afford L2 (0.73 g, 41%) as a white solid. 1H NMR (400 MHz, CD2Cl2): 12.71 (s, 1H), 8.01 – 7.94 (m, 1H), 7.90 (d, J = 7.9 Hz, 1H), 7.81 (d, J = 8.0 Hz, 1H), 7.47 – 7.30 (m, 5H), 7.25 – 7.18 (m, 1H), 7.15 (d, J = 2.6 Hz, 1H), 4.00 – 3.77 (m, 2H), 2.80 (s, 6H), 1.67 – 1.52 (m, 1H), 1.11 – 0.80 (m, 2H), 0.63 (t, J = 7.4 Hz, 3H), 0.50 (d, J = 6.7 Hz, 3H). 13C NMR (101 MHz, CD2Cl2): 155.04, 152.25, 151.82, 150.04, 147.86, 144.45, 142.42, 136.37, 134.76, 123.10, 122.55, 122.41, 121.99, 119.44, 119.27, 111.48, 111.36, 108.01, 104.02, 49.56, 38.85, 35.43, 26.86, 16.58, 10.76. ESI‐MS calculated for [C26H28N6 + H]+ ([L2 + H]+): m/z 425.3; found: 425.6. Elemental analysis calculated for C26H28N6·0.3CH2Cl2 (L2·0.3CH2Cl2) (%): C 70.19, H 6.41, N 18.67; found (%): C 70.47, H 6.25, N 18.57. = + 3.15 (c = 1.05, CH2Cl2).
[L2Eu(hfac)3]
A mixture of L2 (0.2 g, 0.47 mmol) and [digEu(hfac)3] (0.47 g, 0.52 mmol) in CH2Cl2 (5 mL) was stirred at r.t for 30 minutes and then evaporated to dryness. The residue was purified by precipitation in pentane to afford [L2Eu(hfac)3] as a white solid (0.52 g, 92%). 1H NMR (400 MHz, CD2Cl2): 24.21 (br, 1H), 18.87 (br, 1H), 11.42 (br, 1H), 10.69 (br, 1H), 10.43 (br, 1H), 9.86 (t, J = 7.7 Hz, 1H), 9.67 (t, J = 7.6 Hz, 1H), 8.59 (d, J = 7.1 Hz, 1H), 8.49 (d, J = 8.4 Hz, 1H), 5.56 (s, 1H), 4.87 (dd, J = 15.8, 7.0 Hz, 1H), 4.74 (dd, J = 15.7, 8.3 Hz, 1H), 3.97 (br, 1H), 3.17 (s, 6H), 3.11 (s, 3H), 2.25 (br, 1H), 1.91–1.82 (m, 1H), 1.63–1.48 (m, 1H), 1.17 (d, J = 6.5 Hz, 3H), 0.95 (t, J = 7.4 Hz, 3H). 13C NMR (101 MHz, CD2Cl2): 160.84, 160.51, 160.17, 159.84, 159.58, 157.68, 156.32, 152.98, 144.13, 142.07, 132.83, 131.99, 130.88, 130.23, 129.68, 127.83, 127.74, 118.49, 112.90, 111.54, 75.95, 74.55, 63.92, 61.93, 61.07, 58.22, 55.37, 50.47, 38.76, 37.36, 27.28, 16.60, 10.97. ESI‐MS calculated for [C41H31N6O6F18Eu – hfac]+ ([[L2Eu(hfac)3] – hfac]+): m/z 991.1; found: 991.7. Elemental analysis calculated for C41H31N6O6F18Eu ([L2Eu(hfac)3]) (%): C 41.12, H 2.61, N 7.02; found (%): C 40.81, H 2.63, N 6.95. = ‐3.97 (c = 0.37, CH2Cl2).
Supporting Information
The authors have cited additional references within the Supporting Information (SI).[ 55 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 ] SI contains the following information: Experimental Section, 1D, and 2D NMR spectra, crystal structures, thermodynamic data, and photophysical data for synthesized compounds.
Conflict of Interest
The authors declare no conflict of interest
Supporting information
Supporting Information
Supporting Information
Acknowledgments
This work is supported from the Swiss National Science Foundation (grant 200020_207313).
Open access publishing facilitated by Universite de Geneve, as part of the Wiley ‐ Universite de Geneve agreement via the Consortium Of Swiss Academic Libraries.
Contributor Information
Dr. Giau Le‐Hoang, Email: hoang.le@unige.ch.
Prof. & Dr. Claude Piguet, Email: claude.piguet@unige.ch.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
- 1. Michael A., J. Prakt. Chem. 1887, 35, 349. [Google Scholar]
- 2. Tokoroyama T., Eur. J. Org. Chem. 2010, 10, 2009. [Google Scholar]
- 3. Mather B. D., Viswanathan K., Miller K. M., Long T. E., Prog. Polym. Sci. 2006, 31, 487. [Google Scholar]
- 4. Hui C., Pu F., Xu J., Chem. Eur J. 2017, 23, 4023. [DOI] [PubMed] [Google Scholar]
- 5. Zhang Y., Wang W., Catal. Sci. Technol. 2012, 2, 42. [Google Scholar]
- 6. Das T., Mohapatra S., Mishra N. P., Nayak S., Raiguru B. P., ChemistrySelect 2021, 6, 3745. [Google Scholar]
- 7. Okino T., Hoashi Y., Takemoto Y., J. Am. Chem. Soc. 2003, 125, 12672. [DOI] [PubMed] [Google Scholar]
- 8. Bécart D., Diemer V., Salaün A., Oiarbide M., Nelli Y. R., Kauffmann B., Fischer L., Palomo C., Guichard G., J. Am. Chem. Soc. 2017, 139, 12524. [DOI] [PubMed] [Google Scholar]
- 9. Liu W., Zou L., Fu B., Wang X., Wang K., Sun Z., Peng F., Wang W., Shao Z., J. Org. Chem. 2016, 81, 8296. [DOI] [PubMed] [Google Scholar]
- 10. Ding P.‐G., Zhou F., Wang X., Zhao Q.‐H., Yu J.‐S., Zhou J., Chem. Sci. 2020, 11, 3852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Berry R. W. H., Mazza R. J., Sullivan S. F., Makromol. Chem. 1984, 185, 559. [Google Scholar]
- 12. Liu J., Yang Z., Liu X., Wang Z., Liu Y., Bai S., Lin L., Feng X., Org. Biomol. Chem. 2009, 7, 4120. [DOI] [PubMed] [Google Scholar]
- 13. Wu F., Li H., Hong R., Deng L., Angew. Chem. Int. Ed. 2006, 45, 947. [DOI] [PubMed] [Google Scholar]
- 14. Wang J., Li H., Zu L., Jiang W., Xie H., Duan W., Wang W., J. Am. Chem. Soc. 2006, 128, 12652. [DOI] [PubMed] [Google Scholar]
- 15. Rabalakos C., Wulff W. D., J. Am. Chem. Soc. 2008, 130, 13524. [DOI] [PubMed] [Google Scholar]
- 16. Malerich J. P., Hagihara K., Rawal V. H., J. Am. Chem. Soc. 2008, 130, 14416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Okino T., Hoashi Y., Furukawa T., Xu X., Takemoto Y., J. Am. Chem. Soc. 2005, 127, 119. [DOI] [PubMed] [Google Scholar]
- 18. Li Z., Li X., Cheng J.‐P., Synlett 2019, 30, 1940. [Google Scholar]
- 19. Pliego J. R., Phys. Chem. Chem. Phys. 2020, 22, 11529. [DOI] [PubMed] [Google Scholar]
- 20. Sauvage J. P., Acc. Chem. Res. 1990, 23, 319. [Google Scholar]
- 21. Beves J. E., Blight B. A., Campbell C. J., Leigh D. A., McBurney R. T., Angew. Chem. Int. Ed. 2011, 50, 9260. [DOI] [PubMed] [Google Scholar]
- 22. Aucagne V., Hänni K. D., Leigh D. A., Lusby P. J., Walker D. B., J. Am. Chem. Soc. 2006, 128, 2186. [DOI] [PubMed] [Google Scholar]
- 23. Lincheneau C., Jean‐Denis B., Gunnlaugsson T., Chem. Commun. 2014, 50, 2857. [DOI] [PubMed] [Google Scholar]
- 24. Ayme J.‐F., Gil‐Ramírez G., Leigh D. A., Lemonnier J.‐F., Markevicius A., Muryn C. A., Zhang G., J. Am. Chem. Soc. 2014, 136, 13142. [DOI] [PubMed] [Google Scholar]
- 25. Le‐Hoang G., Guénée L., Naseri S., Besnard C., Piguet C., Helv. Chim. Acta 2023, 106, e202200190. [Google Scholar]
- 26. Le‐Hoang G., Guénée L., Sommer Q., Piguet C., Inorg. Chem. 2024, 63, 3712. [DOI] [PubMed] [Google Scholar]
- 27. Le‐Hoang G., Guénée L., Bertrand‐Avebe M., Babel L., Rosspeintner A., Piguet C., Inorg. Chem. 2025, 64, 3941. [DOI] [PubMed] [Google Scholar]
- 28. Bünzli J.‐L. G., Piguet C., Chem. Soc. Rev. 2005, 34, 1048. [DOI] [PubMed] [Google Scholar]
- 29. Heffern M. C., Matosziuk L. M., Meade T. J., Chem. Rev. 2014, 114, 4496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Boddula R., Tagare J., Singh K., Vaidyanathan S., Mater. Chem. Front. 2021, 5, 3159. [Google Scholar]
- 31. Lewandowski E. C., Arban C. B., Deal M. P., Batchev A. L., Allen M. J., Chem. Commun. 2024, 60, 10655. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Moore E. G., Samuel A. P. S., Raymond K. N., Acc. Chem. Res. 2009, 42, 542. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Latva M., Takalo H., Mukkala V.‐M., Matachescu C., Rodríguez‐Ubis J. C., Kankare J., J. Lumin. 1997, 75, 149. [Google Scholar]
- 34. Korshunov V. M., Kiskin M. A., Taydakov I. V., J. Lumin. 2022, 251, 119235. [Google Scholar]
- 35. Carneiro Neto A. N., Moura R. T., Carlos L. D., Malta O. L., Sanadar M., Melchior A., Kraka E., Ruggieri S., Bettinelli M., Piccinelli F., Inorg. Chem. 2022, 61, 16333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Arrué L., Santoyo‐Flores J., Pizarro N., Zarate X., Páez‐Hernández D., Schott E., Chem. Phys. Lett. 2021, 773, 138600. [Google Scholar]
- 37. Tsorieva A. V., Korshunov V. M., Metlin M. T., Vlasova T. S., Gontcharenko V. E., Metlina D. A., Kompanets V. O., Chekalin S. V., Taydakov I. V., Mater. Chem. Front. 2025, 9, 809. [Google Scholar]
- 38. Zaïm A., Nozary H., Guénée L., Besnard C., Lemonnier J.‐F., Petoud S., Piguet C., Chem. ‐ Eur. J. 2012, 18, 7155. [DOI] [PubMed] [Google Scholar]
- 39. Lemonnier J.‐F., Guénée L., Beuchat C., Wesolowski T. A., Mukherjee P., Waldeck D. H., Gogik K. A., Petoud S., Piguet C., J. Am. Chem. Soc. 2011, 133, 16219. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Malandrino G., Fragalà I. L., Coord. Chem. Rev. 2006, 250, 1605. [Google Scholar]
- 41. Constable E. C., Adv. Inorg. Chem. Radiochem. 1986, 30, 69. [Google Scholar]
- 42. Piguet C., Bocquet B., Müller E., Williams A. F., Helv. Chim. Acta 1989, 72, 323. [Google Scholar]
- 43. Baudet K., Kale V., Mirzakhani M., Babel L., Naseri S., Besnard C., Nozary H., Piguet C., Inorg. Chem. 2020, 59, 62. [DOI] [PubMed] [Google Scholar]
- 44. Blomquist A. T., Tapp W. J., Johnson J. R., J. Am. Chem. Soc. 1945, 67, 1519. [Google Scholar]
- 45. Ellis D. W., Solomon B. S., J. Chem. Phys. 1967, 46, 3497. [Google Scholar]
- 46. McClure D. S., J. Chem. Phys. 1949, 17, 905. [Google Scholar]
- 47. Nijegorodov N., Luhanga P. V. C., Nkoma J. S., Winkoun D. P., Spectrochimica Acta Part A 2006, 64, 1. [DOI] [PubMed] [Google Scholar]
- 48. Beeby A., Findlay K., Low P. J., Marder T. B., J. Am. Chem. Soc. 2002, 124, 8280. [DOI] [PubMed] [Google Scholar]
- 49. Schulman E. M., Parker R. T., J. Phys. Chem. 1977, 81, 1932. [Google Scholar]
- 50. Naqvi K. R., Donatsch J., Wild U. P., Chem. Phys. Lett. 1975, 34, 285. [Google Scholar]
- 51. Wong K. S., Wang H., Lanzani G., Chem. Phys. Lett. 1998, 288, 59. [Google Scholar]
- 52. Shukla D., Wan P., J. Am. Chem. Soc. 1993, 115, 2990. [Google Scholar]
- 53. Ji M., Ma X., Ind. Chem. Mater. 2023, 1, 582. [Google Scholar]
- 54. Hommes P., Fischer C., Lindner C., Zipse H., Reissig H.‐U., Angew. Chem. Int. Ed. 2014, 53, 7647. [DOI] [PubMed] [Google Scholar]
- 55. Malandrino G., Bettinelli M., Speghini A., Fragalà I., Eur. J. Inorg. Chem. 2001, 2001, 1039. :AID‐EJIC1039>3.0.CO;2‐2. [Google Scholar]
- 56. CCDC numbers: Deposition Number(s) 2472888 (for L1·CH2Cl2), 2472889 (for L2·0.5CH2Cl2), 2472890 (for L3), 2472891 (for L4·CH3OH·2H2O), 2472892 (for L5), 2472893 (for [L2Eu(hfac)3]·0.25CH2Cl2·0.5C6H14), 2472894 (for [L3Eu(hfac)3]), 2472895 (for [L5Eu(hfac)3]·H2O), 2472896 (for [L6Eu(hfac)3]), 2472897 (for [L7Eu(hfac)3]), 2472898 (for [L8Eu(hfac)3]·0.25CH2Cl2) and 2472899‐2472900‐2472901 (for compound 3 at 180 K, 150 K and 120 K) contain(s) the supplementary crystallographic data for this paper. These data are provided free of charge by the joint Cambridge Crystallographic Data Centre and Fachinformationszentrum Karlsruhe Access Structures service.
- 57. Froidevaux P., Harrowfield J. M., Sobolev A. N., Inorg. Chem. 2000, 39, 4678. [DOI] [PubMed] [Google Scholar]
- 58. Malandrino G., Nigro R., Fragalà I., Benelli C., Eur. J. Inorg. Chem. 2004, 3, 500. [Google Scholar]
- 59. Sheldrick G. M., Acta Cryst 2015, C71, 3. [Google Scholar]
- 60. Sheldrick G. M., Acta Cryst 2008, A64, 112. [Google Scholar]
- 61. Dolomanov O. V., Bourhis L. J., Gildea R. J., Howard J. A. K., Puschmann H., J. Appl. Cryst. 2009, 42, 339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Farrugia L., J. Appl. Cryst. 1997, 30, 565. [Google Scholar]
- 63. Castellano B. M., Eggers D. K., J. Phys. Chem. B 2013, 117, 8180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Eggers D. K., Le J. M., Nahm N. T., Pham D. N., Castellano B. M., ACS Omega 2024, 48, 928. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supporting Information
Supporting Information
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
